Business Description
Sharp Therapeutics Corp
NAICS : 541720
SIC : 3741
ISIN : CA8200092077
Description
Sharp Therapeutics Corp is a preclinical-stage drug discovery company developing therapeutics for genetic diseases. It has developed the patent-protected Disco discovery platform consisting of the CoreX biology, AlloChem chemistry, and Mine computational technologies to discover drugs that selectively activate the protein thats been altered by gene mutation. The company has targeted its discovery engine (Disco) to three hereditary disorders with high unmet need, which include Gauchers Disease, Familial Frontotemporal Dementia, and Niemann Pick Type-C. Its drug development pipeline consists of the following candidates: SEL-148, 721, SEL-148, 742, and SEL-145, 793. Geographically, the company's business operations are carried out in the United States of America.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.75 | |||||
Equity-to-Asset | -0.09 | |||||
Debt-to-Equity | -7.25 | |||||
Debt-to-EBITDA | -0.21 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 0.02 | |||||
3-1 Month Momentum % | -2.33 | |||||
6-1 Month Momentum % | 23.53 | |||||
12-1 Month Momentum % | 320 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.06 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 0.26 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -558.11 | |||||
ROA % | -183.98 | |||||
ROIC % | -365.81 | |||||
ROC (Joel Greenblatt) % | -626.5 | |||||
ROCE % | -258.49 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -3.28 | |||||
EV-to-EBITDA | -3.33 | |||||
EV-to-FCF | -4.14 | |||||
Earnings Yield (Greenblatt) % | -30.49 | |||||
FCF Yield % | -24.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sharp Therapeutics Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.31 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 603.83 | ||
| 14-Day RSI | 0.02 | ||
| 14-Day ATR (C$) | 0.025683 | ||
| 20-Day SMA (C$) | 1.065 | ||
| 12-1 Month Momentum % | 320 | ||
| 52-Week Range (C$) | 0.23 - 5 | ||
| Shares Outstanding (Mil) | 30.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sharp Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sharp Therapeutics Corp Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2025-01-27 | 2.20 (+0.00%) |
Show
Entries
Sharp Therapeutics Corp Frequently Asked Questions
What is Sharp Therapeutics Corp(TSXV:SHRX)'s stock price today?
The current price of TSXV:SHRX is C$0.91. The 52 week high of TSXV:SHRX is C$5.00 and 52 week low is C$0.23.
When is next earnings date of Sharp Therapeutics Corp(TSXV:SHRX)?
The next earnings date of Sharp Therapeutics Corp(TSXV:SHRX) is .
Does Sharp Therapeutics Corp(TSXV:SHRX) pay dividends? If so, how much?
Sharp Therapeutics Corp(TSXV:SHRX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sharp Therapeutics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers